Skip to content

Powered by Doctor Evidence
  • GROWTH
  • Programs
    • GROWTH Evidence
    • GROWTH Research
    • GROWTH Value
    • GROWTH Replicator
    • GROWTH Map
  • Technology
  • Knowledge
    • Commentaries
    • Publications
  • About
    • Team
    • Events
    • News
    • Contact
    • Members login

Tag: Assessing the Evidence

Advancing quality and science in the practice guideline enterprise using AGREE

October 22, 2016 Melissa Brouwers, PhD

Assessing the Evidence Series By Melissa Brouwers, PhD Introduction Practice guidelines are a terrific idea. They provide recommendations, based on…

Continue Reading →

Posted in: Commentaries Author Filed under: Assessing the Evidence, Evidence-Based Medicine, Guideline Development, Quality Assessment, Quality of Evidence

From Evidence to Decision

September 15, 2016 Pablo Alonso Coello, MD, PhD

Assessing the Evidence Series By Pablo Alonso Coello, MD, PhD  Introduction Decision-makers do not have an easy job. Several factors…

Continue Reading →

Posted in: Commentaries Author Filed under: Assessing the Evidence, GRADE, Guideline Development, Quality Assessment, Quality of Evidence

Body of Evidence and GRADE

August 15, 2016 Philipp Dahm, MD, MHSc

Assessing the Evidence Series By Philipp Dahm, MD, MHSc On behalf of the U.S. GRADE Network  Introduction It is hard…

Continue Reading →

Posted in: Commentaries Author Filed under: Assessing the Evidence, GRADE, Guideline Development, Quality Assessment, Quality of Evidence

Gaining confidence in the findings of observational studies

July 15, 2016 Eddy Lang, MD

Assessing the Evidence Series By Eddy Lang, MD Introduction The emergence of evidence-based medicine (EBM) in the 1980s resulted in…

Continue Reading →

Posted in: Commentaries Author Filed under: Assessing the Evidence, GRADE, Guideline Development, Observational Studies, Quality Assessment, Quality of Evidence

Risk of Bias in Randomized Trials

June 15, 2016 Gordon H Guyatt, MD, MSc and Jason W Busse, DC, PhD

Assessing the Evidence Series By Gordon H. Guyatt, MD, MSc and Jason W. Busse, DC, PhD Risk of Bias: A Better…

Continue Reading →

Posted in: Commentaries Author Filed under: Assessing the Evidence, GRADE, Guideline Development, Quality Assessment, Quality of Evidence, Randomized Controlled Trials

Evaluating Systematic Review Quality

May 15, 2016 Diekemper et all.

Assessing the Evidence Series By Rebecca L Diekemper, MPH, Doctor Evidence, Santa Monica, CA, Belinda K Ireland, MD, MS, TheEvidenceDoc,…

Continue Reading →

Posted in: Commentaries Author Filed under: Assessing the Evidence, Guideline Development, Quality Assessment, Quality of Evidence, Systematic Reviews

Assessing the Evidence: Series Launch

April 15, 2016 Craig Whittington, PhD and Jacob Franek

Assessing the Evidence Series By Crag Whittington, PhD and Jacob Franek Introduction GROWTH commentaries started in November 2014, and have covered a…

Continue Reading →

Posted in: Commentaries Author Filed under: Assessing the Evidence, Guideline Development, Quality Assessment, Quality of Evidence

GROWTH: 1000 subscribers and counting!

reCAPTCHA is required.

Recent Systematic Reviews

  • Screening for Lung Cancer: CHEST Guideline and Expert Panel Report
  • Effect of Dysphagia Screening Strategies on Clinical Outcomes After Stroke: A Systematic Review for the 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke
  • ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults
  • Systematic Review for the 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
  • Pacing as a Treatment for Reflex-Mediated (Vasovagal, Situational, or Carotid Sinus Hypersensitivity) Syncope: A Systematic Review for the 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope

Contact Us!

reCAPTCHA is required.

Previous Commentaries

  • December 2018: EBM and Public Policy: Obstacles and Opportunities in Congress~Author: Tom Allen
  • November 2018: Understanding How Health Systems View the Pros and Cons of Different Evidence Types~ Authors: C. Michael White, PharmD and Gillian D. Sanders Schmidler, PhD
  • October 2018: New Opportunities for Evidence-Based Policymaking in Health Care~ Author: Sherry Glied, MS, PhD
  • September 2018: The Problem with Gun Violence Research: Fear of Uncomfortable Answers~ Author: Alan I. Leshner, MS, PhD
  • August 2018: Making Peace with My Friend Jay Dickey~ Author: Mark Rosenberg, MD, MPP
  • July 2018: Real-World Evidence to Increase Value in Health Care~Author: McClellan et al.
  • June 2018: The Opacity of Transparency: The Search for a Cure to Our Health Care Woes~Author: Niall Brennan, MPP
  • May 2018: Why Evidence Matters for Universal Health Coverage: A Perspective from the World Bank Group~Author: Timothy G. Evans, MD, PhD
  • April 2018: Contemporary Health Policymaking: Where’s the Evidence?~ Author: Susan Dentzer
  • March 2018: Designing a New Medical School for the 21st Century: Kaiser Permanente School of Medicine~Author: Craig W Robbins, MD,MPH
  • February 2018: Winds of Change in Publishing~Author: David Sampson, MBA
  • January 2018: American Heart Association and American College of Cardiology Guideline Modernization Program/Initiative~Author: Abdul R. Abdullah, M.D.
  • December 2017: Data and Analytics: The Backbone of Global Health~Author: Trevor Mundel, PhD
  • November 2017: Resolve: What It Is, Why It’s Needed~Author: Thomas R. Frieden, MD, MPH
  • October 2017: Understanding Global Health Statistics through Visual Presentations~An Interview with Anna Rosling-Rönnlund, Gapminder Co-Founder and Vice President
  • September 2017: Producing guidelines for public health emergencies~Authors: Mauricio Ferri, MD, MS and Susan L Norris, MD, MPH, MS
  • August 2017: Measuring the Impact of Public Health Interventions: (Almost) as Important as the Work Itself~Author: Rebecca Martin, PhD
  • July 2017: Health Systems – Why do they matter for the developing world?~Author: Kelly Saldaña, MPH
  • June 2017: Expanding Transparency in Health Estimation~Author: Christopher J. L. Murray, MD, DPhil
  • May 2017: The Long History and Bright Future of Artificial Intelligence in Medicine~Author: Joël Kuiper
  • April 2017: A brief overview of development and implementation of clinical practice guidelines in Mexico~Author: José Luis Mayorga Butrón, MD, MSc
  • March 2017: Reliable and relevant systematic-reviews/meta-analyses to facilitate guideline production for healthcare: Still room for improvement~Authors: Heidi Tibollo, MLS, and Todd Feinman, MD
  • February 2017: ‘Unconference’ to Cap Dual Guideline Events~Author: Peter Wyer, MD
  • January 2017: What will 2017 Mean for Evidence~Author: Lisa Simpson, MB, BCh, MPH
  • November 2016: Guidelines and Multimorbidity~Author: Cynthia Boyd, MD, MPH
  • October 2016: Advancing quality and science in the practice guideline enterprise using AGREE~Author: Melissa Brouwers, PhD
  • September 2016: From Evidence to Decision~Author: Pablo Alonso Coello, MD, PhD
  • August 2016: Body of Evidence and GRADE~Author: Philipp Dahm, MD
  • July 2016: Gaining confidence in the findings of observational studies~Author: Eddy Lang, MD
  • June 2016: Risk of Bias in Randomized Trials~Authors: Gordon H. Guyatt, MD, MSc and Jason W. Busse, DC, PhD
  • May 2016: Evaluating Systematic Review Quality~Authors: Rebecca L Diekemper, MPH, Belinda K Ireland, MD, MS, and Liana R Merz, PhD, MPH
  • April 2016: Assessing the Evidence – Series Launch~Authors: Craig Whittington, PhD & Jacob Franek
  • March 2016: Putting the Evidence into AHRQ’s EvidenceNOW~Author: David Meyers, MD
  • February 2016: Implementing Person-Centered Care through Guidelines~Author: Anna R Gagliardi, PhD
  • October 2015: The Power of Reliable Evidence~Authors: Michael E. Stuart MD, and Sheri Ann Strite
  • September 2015: The Institute of Medicine Standards for Systematic Reviews: 4 Years Later~Author: Sally C. Morton, PhD
  • August 2015: What is the impact of the IOM Clinical Practice Guidelines Report on consumer stakeholder involvement?~Author: Peg Ford
  • July 2015: Effects of the IOM Reports: A Guideline Developer’s Perspective~Author: Tom Oliver
  • June 2015: What a difference a year makes: 1 year after implementing the AHRQ National Guidelines~Author: Mary P. Nix, MS, PMP
  • May 2015: The Institute of Medicine Standards for Trustworthy Clinical Practice Guidelines: 4 Years Later~Author: Sheldon Greenfield, MD
  • April 2015: The Guidelines International Network/North America Community: We’ve Come a Long Way~Author: Marguerite Koster, MA, MFT
  • March 2015: Initiating a Discussion: Challenges and Opportunities for Use of Real World Data~Author: Sandra Zelman Lewis, PhD
  • February 2015: Orchestrating people, process, and technology in the development and implementation of evidence-based guidelines~Author: Craig W Robbins, MD, MPH
  • January 2015: The Evolution of Technology~Author: Craig Whittington, PhD
  • November 2014: GROWTH Commentaries Announcement: The Launch of GROWTH Commentaries

Topics

Affordable Care Act Agency for Healthcare Research and Quality Assessing the Evidence Cardiovascular Comparative Effectiveness Research Data and Analytics Digital Evidence Digital Health Epidemiology Evidence-Based Health Policy Evidence-Based Medicine Future of Healthcare Global Health GRADE Guideline Development Guideline Implementation Guidelines International Network Healthcare Costs Healthcare Policy Health Systems Institute of Medicine Institutional Change IOM Standards Meta-analysis Multiple Chronic Conditions National Guideline Clearinghouse Observational Studies Oncology Patient-centered Care Patient Engagement Patient Level Data primary care Publishing Quality Assessment Quality Improvement Quality of Evidence Randomized Controlled Trials Real-world Evidence Systematic Reviews Technology

Recent Posts

  • Continuing the Exploration of Guideline Dissemination Through Social Media
  • 15 Years Past, Present, & Future: Being Digital
  • EBM and Public Policy: Obstacles and Opportunities in Congress

SEARCH GROWTH

  • Privacy Policy
reCAPTCHA is required.
  • Twitter
  • Facebook
Copyright © 2019 — Lyrical WordPress theme by GoDaddy
Scroll Up